← Back to Chinese Version
Song Xin_Ophthalmology, Shanghai Ninth People's Hospital_Eyelid Tumor, Ocular Tumor & Oculoplastic Expert

Song Xin_Ophthalmology, Shanghai Ninth People's Hospital_Eyelid Tumor, Ocular Tumor & Oculoplastic Expert (宋欣)

Hotline: 400-616-6769
WeChat: wuyoubianmei (Click to Copy)
Song Xin, MD, Associate Chief Physician at the Department of Ophthalmology, Shanghai Ninth People's Hospital, specializes in the diagnosis and treatment of eyelid tumors and orbital tumors.

Biography

Areas of Expertise

Song Xin, MD, Associate Chief Physician at the Department of Ophthalmology, Shanghai Ninth People's Hospital, specializes in the diagnosis and treatment of eyelid tumors and orbital tumors.

Biography

宋欣医生

Song Xin, PhD, Associate Chief Physician, is a certified expert for the Ocular Tumor Guidelines of the China Anti-Cancer Association. He trained under Professor Xianqun Fan, Academician of the Chinese Academy of Engineering. His professional focus is ocular tumors and orbital diseases. He is particularly skilled in the diagnosis and treatment of eyelid tumors and orbital tumors. The department he works in is a National Key Clinical Specialty, a Shanghai Key Discipline, and a Shanghai “Top Priority” Medical Key Discipline. He completed long-term advanced training at world-leading eye hospitals——Bascom Palmer Eye Institute in the United States and Moorfields Eye Hospital in the United Kingdom.

Professional Appointments
Member, Ocular Tumor Committee, China Anti-Cancer Association
Member, Orbital Disease and Oculoplastic Surgery Group, Ophthalmology Branch, Shanghai Medical Association
Ophthalmology Branch, Shanghai Medical Doctor Association

Awards and Honors
As a key member, he received the 2018 National Science and Technology Progress Award, Second Prize, for “Establishment and Application of a Key Diagnostic and Treatment Technology System for Eyelid and Orbital Malignancies”; the 2017 Shanghai Science and Technology Progress Award, First Prize, for “Establishment and Application of Key Diagnostic and Treatment Technologies for Intraocular Malignancies”; and the 2013 Shanghai Science and Technology Progress Award, First Prize, for “Gene-Targeted Therapy and Clinical Treatment of Ocular Tumors”, among other awards. He has been awarded titles including “Shanghai Outstanding Young Physician”, Shanghai Jiao Tong University “Morning Star Young Scholar”, and Hospital “Outstanding Young Core Talent”.

Research Achievements
He has published more than 20 SCI-indexed papers in international journals.
He has led one National Natural Science Foundation of China project in the field of ocular tumors and other municipal and bureau-level projects, including those from the Shanghai Municipal Education Commission. As a key member, he participated in the compilation of ocular oncology monographs and guidelines, including Clinical Ocular Oncology, Integrative Oncology, China Anti-Cancer Association—Guideline for Lacrimal Gland Adenoid Cystic Carcinoma, China Anti-Cancer Association—Guideline for Sebaceous Carcinoma, and Complex Diseases of the Sensory System.

Expertise in Comprehensive Diagnosis and Treatment of Ocular Tumors and Orbital Diseases. In particular:
I. Ocular Tumors
1. Eyelid tumors (sebaceous carcinoma, squamous cell carcinoma, basal cell carcinoma, melanoma, Merkel cell carcinoma, sweat gland carcinoma, etc.)
2. Orbital tumors (lacrimal gland tumors, solitary fibrous tumor, schwannoma, meningioma, lymphoma, neurofibroma, rhabdomyosarcoma, etc.)
3. Conjunctival tumors (melanoma, lymphoma, squamous cell carcinoma, etc.)
II. Orbital Diseases
1. Inflammatory pseudotumor
2. Vascular malformations: cavernous hemangioma, venous malformation, vascular malformation, etc.
3. Sarcoidosis, Kimura disease, histiocytosis, IgG4-related ophthalmic disease, etc.

Book a Free Consultation